Assay Designs Raises $5M in Series A Financing

Ann Arbor, Mich.-based Assay Designs said last week that it has recently received a $5 million Series A equity investment from Ampersand Ventures.

Ampersand was the sole investor in the financing round, which was the first in Assay Designs' history.

Assay Designs, founded in 1992, develops and manufactures immunoassay kits, luminescent reagents, antibodies, and proteins for the life sciences research market.

Protedyne Opens UK Office

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.